Ignite Creation Date:
2024-05-06 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 2:28 PM
Study NCT ID:
NCT05297240
Status:
UNKNOWN
Last Update Posted:
2022-08-05
First Post:
2022-03-17
Brief Title:
Retrospective Study of the Use of Belantamab Mafodotin Blenrep in Patients With Relapsed andor Refractory Multiple Myeloma RRMM in Spain
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Organization Data
Organization:
PETHEMA Foundation
Class:
OTHER
Study ID:
GEM-RELAMAB
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PETHEMA Foundation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |